{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T17:20:17Z","timestamp":1758820817702},"reference-count":29,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,4,1]]},"abstract":"<jats:p>We identified two homozygous missense mutations in the human type II 3\u03b2-hydroxysteroid dehydrogenase (3\u03b2HSD) gene, the first in codon 6 of exon II [CTT (Leu) to TTT (Phe)] in a male infant with hyperpigmented scrotum and hypospadias, raised as a male and no apparent salt-wasting since neonatal age, and the second in codon 259 of exon IV [ACG (Thr) to ATG (Met)] in a male pseudohermaphrodite with labial scrotal folds, microphallus, chordee, and fourth degree hypospadias, raised as a female and with salt-wasting disorder since neonatal age. In vitro transient expression of mutant type II 3\u03b2HSD complementary DNAs of L6F, T259M, as well as T259R for comparison was examined by a site-directed mutagenesis and transfection of construct into COS-1 and COS-7 cells. Northern blot analysis revealed expression of similar amounts of type II 3\u03b2HSD messenger ribonucleic acid from the COS-1 cells transfected by L6F, T259M, T259R, and wild-type (WT) complementary DNAs. Western immunoblot analysis revealed a similar amount of L6F mutant protein compared to WT enzyme from COS-1 cells, but neither L6F from COS-7 cells nor T259M or T259R mutant protein in COS-1 or COS-7 cells was detectable. Enzyme activity in intact COS-1 cells using 1 \u03bcmol\/L pregnenolone as substrate in the medium after 6 h revealed relative conversion rates of pregnenolone to progesterone of 46% by WT enzyme, 22% by L6F enzyme, and 8% by T259M enzyme and less than 4% activity by T259R enzyme. Using 1 \u03bcmol\/L dehydroepiandrosterone as substrate, the relative conversion rate of dehydroepiandrosterone to androstenedione after 6 was 89% by WT enzyme, 35% by L6F enzyme, 5.1% by T259M enzyme and no activity by T259R enzyme. However, the L6F mutant 3\u03b2HSD activity, despite its demonstration in the intact cells, was not detected in homogenates of COS-1 cells or in immunoblots of COS-7 cells, suggestive of the relatively unstable nature of this protein in vitro, possibly attributable to the decreased 3\u03b2HSD activity. In the case of T259M and T259R mutations, consistently undetectable proteins in both COS cells despite detectable messenger ribonucleic acids indicate severely labile proteins resulting in either no or very little enzyme activity, and these data further substantiate the deleterious effect of a structural change in this predicted putative steroid-binding domain of the gene. In conclusion, the findings of the in vitro study of mutant type II 3\u03b2HSD enzyme activities correlated with a less severe clinical phenotype of nonsalt-wasting and a lesser degree of genital ambiguity in the patient with homozygous L6F mutation compared to a more severe clinical phenotype of salt-wasting and severe degree of genital ambiguity in the patient with homozygous T259M mutation in the gene.<\/jats:p>","DOI":"10.1210\/jcem.85.4.6539","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:05:32Z","timestamp":1389200732000},"page":"1678-1685","source":"Crossref","is-referenced-by-count":2,"title":["Characterization of Two Novel Homozygous Missense Mutations Involving Codon 6 and 259 of Type II 3\u03b2-Hydroxysteroid Dehydrogenase (3\u03b2HSD) Gene Causing, Respectively, Nonsalt-Wasting and Salt-Wasting 3\u03b2HSD Deficiency Disorder1"],"prefix":"10.1210","volume":"85","author":[{"given":"Li","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Illinois College of Medicine (L.Z., Y.N., Y.T.C., S.P.), Chicago, Illinois 60612"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Ian","family":"Mason","sequence":"additional","affiliation":[{"name":"Department of Reproductive and Developmental Sciences (Clinical Biochemistry), University of Edinburgh (J.I.M.), EH3 9YW Edinburgh, Scotland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Naiki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Illinois College of Medicine (L.Z., Y.N., Y.T.C., S.P.), Chicago, Illinois 60612"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth C.","family":"Copeland","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine (K.C.C.), Houston, Texas 77030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Castro-Magana","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Winthrop University Hospital, State University of New York (M.C.M.), Long Island, New York 11501"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy T.","family":"Gordon-Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying T.","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Illinois College of Medicine (L.Z., Y.N., Y.T.C., S.P.), Chicago, Illinois 60612"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songya","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Illinois College of Medicine (L.Z., Y.N., Y.T.C., S.P.), Chicago, Illinois 60612"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071618502736600_R1","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1210\/mend-5-8-1147","article-title":"Structure, and expression of a new complimentary DNA encoding the almost exclusive 3\u03b2-hydroxysteroid deydrogenase\/\u03945-\u03944-isomerase in human adrenals and gonads.","volume":"5","author":"Rhe\u0301aume","year":"1991","journal-title":"Mol Endocrinol"},{"key":"2020071618502736600_R2","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1210\/mend-4-12-1850","article-title":"Structural analysis of the gene encoding human 3\u03b2-hydroxysteroid dehydrogenase\/\u03944\u21925 isomerase.","volume":"4","author":"Lorence","year":"1990","journal-title":"Mol Endocrinol"},{"key":"2020071618502736600_R3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000132878","article-title":"Assignment of the human 3\u03b2-hydroxysteroid dehydrogenase gene (HSDB3) to the p13 band of the chromosome 1.","volume":"52","author":"Be\u0301rube\u0301","year":"1989","journal-title":"Cytogenet Cell Genet"},{"key":"2020071618502736600_R4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ng0792-239","article-title":"Congenital adrenal hyperplasia due to point mutations in the type II 3\u03b2-hydroxysteroid dehydrogenase gene.","volume":"1","author":"Rhe\u0301aume","year":"1992","journal-title":"Nat Genet"},{"key":"2020071618502736600_R5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1203\/00006450-199311000-00026","article-title":"Mutations in the type II 3\u03b2-hydroxysteroid dehydrogenase gene in a patient with classic salt-wasting 3\u03b2-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia.","volume":"34","author":"Chang","year":"1993","journal-title":"Pediatr Res"},{"key":"2020071618502736600_R6","first-page":"716","article-title":"Molecular basis of congenital adrenal hyperplasia due to 3\u03b2-hydroxysteroid dehydrogenase deficiency.","volume":"7","author":"Simard","year":"1993","journal-title":"Mol Endocrinol"},{"key":"2020071618502736600_R7","first-page":"1012","article-title":"Molecular basis of congenital adrenal hyperplasia in two siblings with classical nonsalt-losing 3\u03b2-hydroxysteroid dehydrogenase deficiency.","volume":"79","author":"Rhe\u0301aume","year":"1994","journal-title":"J Clin Endocinol Metab"},{"key":"2020071618502736600_R8","first-page":"291","article-title":"A new compound heterozygous frameshift mutation in the type II. 3\u03b2-hydroxysteroid dehydrogenase (3\u03b2HSD) gene causes salt-wasting 3\u03b2HSD deficiency congenital adrenal hyperplasia.","volume":"81","author":"Zhang","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618502736600_R9","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1172\/JCI104666","article-title":"The adrenogenital syndrome with deficiency of 3\u03b2-hydroxysteroid dehydrogenase.","volume":"41","author":"Bongiovanni","year":"1962","journal-title":"J Clin Invest"},{"key":"2020071618502736600_R10","first-page":"82","article-title":"The molecular and clinical spectrum of 3\u03b2-hydroxysteroid dehydrogenase deficiency disorder.","volume":"9","year":"1998","journal-title":"TEM"},{"key":"2020071618502736600_R11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2265.1979.tb03111.x","article-title":"Serum androgen concentrations in neonates and young infants with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.","volume":"11","author":"Pang","year":"1979","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071618502736600_R12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1203\/00006450-198001000-00010","article-title":"Plasma levels of aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, cortisol, and cortisone during infancy and childhood.","volume":"14","author":"Sippell","year":"1980","journal-title":"Pediatr Res"},{"key":"2020071618502736600_R13","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1210\/jcem-73-3-674","article-title":"Normative data for adrenal steroidogenesis in a healthy pediatric population: age and sex-related changes after adrenocorticotropin stimulation.","volume":"73","author":"Lashansky","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618502736600_R14","first-page":"3961","article-title":"Studies of 3\u03b2-hydroxy-steroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated \u03945-steroid levels.","volume":"81","author":"Sakkal-Alkaddour","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618502736600_R15","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1210\/jcem-48-5-821","article-title":"Dihydrotestosterone, and its relationship to testosterone in infancy and childhood.","volume":"48","author":"Pang","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618502736600_R16","first-page":"243","article-title":"Normal, and elevated 3\u03b1-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels.","volume":"75","author":"Pang","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618502736600_R17","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1089\/dna.1991.10.701","article-title":"Structure of the human type II 3\u03b2-hydroxysteroid dehydrogenase\/\u03945-\u03944 isomerase (3\u03b2HSD) gene: adrenal and gonadal specificity.","volume":"10","author":"Lachance","year":"1991","journal-title":"DNA Cell Biol"},{"key":"2020071618502736600_R18","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1203\/00006450-199411000-00023","article-title":"Evidence of a steroidogenic enzyme gene dose effect on adrenal gene expression in hereditary rabbit congenital adrenal hyperplasia.","volume":"36","author":"Iwamoto","year":"1994","journal-title":"Pediatr Res"},{"key":"2020071618502736600_R19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3109\/07435809809032645","article-title":"StAR protein is expressed in both medulla, and cortex of the bovine and rat adrenal gland.","volume":"24","author":"Lo","year":"1998","journal-title":"Endocr Res"},{"key":"2020071618502736600_R20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0960-0760(95)00198-0","article-title":"Structure-function relationships and molecular genetics of the 3\u03b2-hydroxysteroid dehydrogenase gene family.","volume":"55","author":"Simard","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071618502736600_R21","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1021\/bi00009a020","article-title":"Identification and characterization of the G15D mutation found in a male patient with 3\u03b2-hydroxysteroid dehydrogenase (3\u03b2HSD) deficiency: alteration of the putative NAD-binding domain of the type II 3\u03b2HSD.","volume":"34","author":"Rhe\u0301aume","year":"1995","journal-title":"Biochemistry"},{"key":"2020071618502736600_R22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/hmg\/3.2.327","article-title":"Congenital adrenal hyperplasia caused by a novel homozygous frameshift mutation 273\u0394AA in type II 3\u03b2-hydroxysteroid dehydrogenase (HSD 3\u03b22) in three male patients of Afghan\/Pakistani origin.","volume":"3","author":"Simard","year":"1994","journal-title":"Hum Mol Genet"},{"key":"2020071618502736600_R23","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/hmg\/3.9.1639","article-title":"Functional characterization of the novel L1994 108W and P186L mutations detected in the type II 3\u03b2-hydroxysteroid dehydrogenase gene of a male pseudohermaphrodite with congenital adrenal hyperplasia.","volume":"3","author":"Sanchez","year":"1994","journal-title":"Hum Mol Genet"},{"key":"2020071618502736600_R24","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/hmg\/4.4.745","article-title":"A novel missense mutation in the type II 3\u03b2-hydroxysteroid dehydrogenase gene in a family with classical salt-wasting congenital adrenal hyperplasia due to 3\u03b2-hydroxysteroid dehydrogenase deficiency.","volume":"4","author":"Katsumata","year":"1995","journal-title":"Hum Mol Genet"},{"key":"2020071618502736600_R25"},{"key":"2020071618502736600_R26","doi-asserted-by":"crossref","first-page":"18507","DOI":"10.1016\/S0021-9258(17)46656-7","article-title":"Affinity radiolabeling identifies peptides and amino acids associated with substrate binding in human placental 3\u03b2-hydroxy-\u03945-steroid dehydrogenase.","volume":"268","author":"Thomas","year":"1993","journal-title":"J Biol Chem"},{"key":"2020071618502736600_R27","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/hmg\/4.5.969","article-title":"Molecular analysis of type II 3\u03b2-hydroxysteroid dehydrogenase gene in Japanese patients with classical 3\u03b2-hydroxysteroid dehydrogenase deficiency.","volume":"4","author":"Tajima","year":"1995","journal-title":"Hum Mol Genet"},{"key":"2020071618502736600_R28","first-page":"561","article-title":"Detection, and functional characterization of the novel missense mutation Y254D in type II 3\u03b2-hydroxysteroid dehydrogenase (3\u03b2HSD) gene of a female patient with non salt-losing 3\u03b2HSD deficiency.","volume":"78","author":"Sanchez","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618502736600_R29"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/4\/1678\/10403260\/jcem1678.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/4\/1678\/10403260\/jcem1678.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:03:15Z","timestamp":1647907395000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/85\/4\/1678\/2855718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4,1]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.85.4.6539","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4,1]]}}}